[1]
2013. Clinical and economic analysis of the feasibility of using Dicarbamine® for the prevention of toxic effects of chemotherapy. Voprosy onkologii. 59, 5 (Dec. 2013), 637–641. DOI:https://doi.org/10.37469/0507-3758-2013-59-5-637-641.